Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO
Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO